Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generics
Pharma
Biocon buys out Viatris and others from biosimilar subsidiary
Returning its stake in Biocon Biologics allows Viatris to re-enter the market it left as a result of its 2022 biosimilar sale to Biocon.
Zoey Becker
Dec 9, 2025 1:56pm
Mark Cuban says FDA should lower fees for generic drug approvals
Dec 5, 2025 4:15pm
Newer drugs came to Novartis' aid as top-selling brands stalled
Oct 28, 2025 11:18am
TROP2 showdown, InnoCare-Zenas, Lupin—Fierce Pharma Asia
Oct 10, 2025 10:55am
Trump carves out generics from US-Japan trade deal
Sep 8, 2025 11:50am
Teva launches first generic version of Novo's GLP-1 Saxenda
Aug 28, 2025 3:45pm
